Nutritional supplement may help prevent Alzheimer's, research suggests

January 10, 2013 by Josh Barney, University of Virginia

(Medical Xpress)—A nutritional supplement available over-the-counter may offer protection from Alzheimer's disease, a study by the University of Virginia and Northwestern University suggests.

Researchers at Northwestern and U.Va.'s School of Medicine set out to evaluate the effectiveness of chiro-inositol, a compound that occurs naturally in certain foods and is available as a , in protecting the brain from beta amyloid toxins, which cause Alzheimer's. They conclude, in a paper published this month in The , that chiro-inositol "greatly enhances" insulin's ability to prevent damage to neurons by toxic peptides called ADDLs. The damage and loss of neurons is believed responsible for Alzheimer's.

The findings indicate potential for a new strategy for developing Alzheimer's disease treatments based on compounds already regarded as safe for human use, the researchers write.

"In Alzheimer's, it's been known for many years that the brain does not utilize glucose very well," U.Va. pharmacology professor emeritus Dr. Joseph Larner said. "Insulin is required to utilize glucose in the brain, just as it's required by muscle, liver and fat to stimulate . What has not been realized until very recently is that this inability of the brain to utilize glucose is caused by . This insulin resistance in the brain has been referred to as type 3 diabetes."

Chiro-inositols essentially help overcome insulin resistance in the brain, the researchers believe. The study showed chiro-inositols greatly improved glucose use in primary cultures of neurons, significantly improving insulin's ability to prevent synapse damage when the cells were challenged with ADDL .

"Chiro is a nutraceutical that we believe sensitizes your brain to the effects of insulin," said David Brautigan, U.Va. professor of microbiology, immunology and . "This would presumably enhance and protect the brain from Alzheimer's."

"It's been shown that chiro-inositol is very safe," added Larner, a pioneer in the field of pharmacology. "It's been used in humans for quite a number of years now. I take it myself."

Encouraged by their findings, the researchers call for further investigation of chiro-inositols, including a clinical trial in humans and further development of drugs containing chiro-inositols. The research also opens new avenues to explore.

"There's been a big argument going on for years about whether insulin is made in the brain and how important insulin is in signaling in the brain. It was thought that glucose uptake in the brain was passive, not regulated by insulin," said U.Va.'s Michael Thorner, David C. Harrison Medical Teaching Professor of Internal Medicine. "It is now appreciated that insulin is in the brain and important for its metabolism. There may even be special forms of insulin in the to stimulate neurons and other cells."

Explore further: New evidence links Alzheimer's disease and diabetes

More information: www.fasebj.org/content/27/1/19 … 5f-a3c9-427ade023b17

Related Stories

New evidence links Alzheimer's disease and diabetes

March 20, 2012
An emerging body of research suggests that Alzheimer's disease may be linked to insulin resistance, constituting a third type of diabetes. This model is based on several observations including an increased risk of developing ...

Link between brain insulin resistance, neuronal stress in worsening Alzheimer's disease

June 26, 2012
Rhode Island Hospital researcher Suzanne de la Monte, M.D., has found a link between brain insulin resistance (diabetes) and two other key mediators of neuronal injury that help Alzheimer's disease (AD) to propagate. The ...

Insulin resistance linked to brain health in elderly

February 1, 2012
New research from Uppsala University shows that reduced insulin sensitivity is linked to smaller brain size and deteriorated language skills in seniors. The findings are now published in the scientific journal Diabetes Care.

Study shows overeating impairs brain insulin function, can lead to diabetes and obesity

October 17, 2012
New research from Mount Sinai School of Medicine sheds light on how overeating can cause a malfunction in brain insulin signaling, and lead to obesity and diabetes. Christoph Buettner, MD, PhD, Associate Professor of Medicine ...

Recommended for you

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

Advances in brain imaging settle debate over spread of key protein in Alzheimer's

January 5, 2018
Recent advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread ...

Molecular mechanism behind HIV-associated dementia revealed

January 5, 2018
For the first time, scientists have identified and inhibited a molecular process that can lead to neurodegeneration in patients with HIV, according to a Northwestern Medicine study published in Nature Communications.

Mice with frequent flier miles advance the Alzheimer's cause

January 4, 2018
Alzheimer's disease wreaks emotional havoc on patients, who are robbed of their memories, their dignity, and their lives. It's financially devastating as well: care for Alzheimer's patients is predicted to top $1 trillion ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.